RE:RE:A little movement on a patentFGPstock this is an older application and is definitely different than the covid item. Some have mentioned Ruvacare but that is a name that I do not see mentioned in the application and right off hand I do not recall where it comes from. This is the abstract from the application I posted:
VACCINE CONTAINING CANCER CELLS INACTIVATED BY PHOTODYNAMIC TREATMENT WITH METAL-BASED COORDINATION COMPLEXES, AND IMMUNOTHERAPY METHOD USING SAME Abstract A method for treating a tumor in a patient by administering to the patient an immunogenic composition including antigenic material inactivated by treatment with a metal-based coordination complex and electromagnetic radiation, wherein the immunogenic composition is effective to elicit an immune response to the antigenic material in the patient after administration and the metal-based coordination complex having a specified formula. An immunogenic composition and a method for preparing it are also disclosed.
| Inventors: | MANDEL; Arkady; (Toronto, CA) |
November 5, 2019 | Applicant: | | Name | City | State | Country | Type |
THERALASE BIOTECH INC. |
Wilmington |
DE |
US | | |
| Family ID: | 64105706 |
| Appl. No.: | 16/610991 |
| Filed: | May 11, 2018 |
| PCT Filed: | May 11, 2018 |
| PCT NO: | PCT/US2018/032274 |
| 371 Date: | |
| United States Patent Application | 20200222450 |
| Kind Code | A1 |
| MANDEL; Arkady | July 16, 2020 |
. The method of claim 1, wherein the immunogenic composition is prepared by collecting tumor cells from a donor, preparing a composition comprising the tumor cells and the metal-based coordination complex, and exposing the composition to the electromagnetic radiation to provide the immunogenic composition.
BACKGROUND OF THE INVENTION
1. Field of Invention
[0001] This invention relates to immunotherapy and more particularly to the combination of immunotherapy and photodynamic therapy.
2. Description of Related Art
[0002] Immunotherapy is recognized as a promising method for treating cancer with much as yet untapped potential. According to a 2016 recent press release from the USPTO regarding the "Cancer Moonshot" initiative, approximately 900 cancer immunotherapy applications are received annually by the USPTO.
[0003] One such application is US 20070025958 A1, which discloses compositions and methods of immunotherapy to treat cancer or other antigen-producing diseases or lesions. The compositions comprise an effective amount of a cytokine mixture, which acts as an adjuvant with the antigen associated with the antigen-producing disease or lesion to enhance the immune response of the patient to the antigen.
That's just a brief excerpt out of the application -- but, as I said, completely separate from the covid related Coombs investigation. Maybe someone can relate it to Ruvacare.
FGPstock wrote: Pandora, would this patent be for something different? "VACCINE CONTAINING CANCER CELLS INACTIVATED". I don't believe either the combs/covid research would fall under this category, nor would a typical TLD treatment be considered a vaccine.
Is this a new treatment to trigger an immune response/antibodies?
Pandora wrote: | 16/610,991 | VACCINE CONTAINING CANCER CELLS INACTIVATED BY PHOTODYNAMIC TREATMENT WITH METAL-BASED COORDINATION COMPLEXES, AND IMMUNOTHERAPY METHOD USING SAME | T1081/20076 |  | | |
| Date | Transaction Description | | 06-24-2022 | Notice of Allowance Data Verification Completed | |